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SUMMARY		 MicroRNAs	(miRNAs)	regulate	many	aspects	of	helper	T	cell	(Th)	development	and	function.	Here	we	found	they	are	required	for	suppression	of	interleukin-9	(IL-9)	expression	in	Th9	cells	and	other	Th	subsets.	Two	highly	related	miRNAs	(miR-15b	and	miR-16)	that	we	previously	found	to	play	an	important	role	in	regulatory	T	cell	(Treg)	differentiation	were	capable	of	supressing	IL-9	expression	when	they	were	overexpressed	in	Th9	cells.	We	used	these	miRNAs	as	tools	to	identify	novel	regulators	of	IL-9	expression	and	found	they	could	regulate	the	expression	of	Epas1,	which	encodes	hypoxia	inducible	factor	(HIF)-2α.	HIF	proteins	regulate	metabolic	pathway	usage	that	is	important	in	determining	appropriate	Th	differentiation.	The	related	protein,	HIF-1α	enhances	Th17	differentiation	and	inhibits	Treg	differentiation.	Here	we	found	that	HIF-2α	was	required	for	IL-9	expression	in	Th9	cells,	but	its	expression	was	not	sufficient	in	other	Th	subsets.	Furthermore,	HIF-2α	suppressed	Treg	differentiation	like	HIF-1α, demonstrating	both	similar	and	distinct	roles	of	the	HIF	proteins	in	Th	differentiation	and	adding	a	further	dimension	to	their	function.	Ironically,	even	though	miR-15b	and	miR-16	suppressed	HIF-2α	expression	in	Tregs,	inhibiting	their	function	in	Tregs	did	not	lead	to	an	increase	in	IL-9	expression.	Therefore,	the	physiologically	relevant	miRNAs	that	regulate	IL-9	expression	in	Tregs	and	other	subsets	remain	unknown.	Nevertheless,	the	analysis	of	miR-15b	and	miR-16	function	led	to	the	discovery	of	the	importance	of	HIF-2α	so	this	work	demonstrated	the	utility	of	studying	miRNA	function	to	identify	novel	regulatory	pathways	in	helper	T	cell	development.			
INTRODUCTION		 IL-9	is	a	cytokine	that	has	recently	received	a	significant	amount	of	attention	for	its	role	in	tumour	immunity	(1,2),	the	immune	clearance	of	certain	helminths	(3),	and	its	role	in	
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autoimmune	responses	leading	to	allergic	airway	inflammation	(4)	and	colitis	(5).	IL-9	can	be	produced	by	mast	cells,	eosinophils,	and	type	two	innate	lymphoid	cells,	but	it	is	primarily	produced	by	Th	cells	(6).	These	include	Th2,	Th17,	and	Treg	cells	(7-10);	however,	the	principal	source	of	IL-9	is	thought	to	be	Th9	cells	(11,12),	which	are	a	newly	identified	subset	defined	by	the	production	of	IL-9	without	the	cytokines	characteristic	of	other	subsets.	Th9	cells	can	be	produced	in	vitro	by	the	activation	of	naïve	CD4+	T	cells	in	the	presence	of	IL-4	and	TGF-β (11-13),	but	their	role	in	vivo	has	been	hard	to	define.	Some	of	the	best	evidence	for	their	importance	has	been	demonstrated	in	mice	with	a	T-cell	specific	deletion	of	PU.1,	which	is	a	transcription	factor	required	for	IL-9	expression	(7).	These	mice	lack	Th9	cells,	but	the	development	of	other	Th	subsets	remains	largely	unaffected.	They	are	resistant	to	airway	inflammation	in	a	model	of	asthma	(7)	and	also	to	ulcerative	colitis	in	a	model	of	inflammatory	bowel	disease	(5).	Understanding	the	development	of	Th9	cells	and	the	regulation	of	IL-9	expression	could	provide	new	inroads	towards	clinical	approaches	to	many	immune	related	diseases.	Transcriptional	regulation	plays	an	important	role	in	IL-9	expression	(14).	Signalling	through	STAT6	is	essential	(11,12,15)	and	so	are	the	transcription	factors	PU.1	(7,16,17),	IRF4	(16),	GATA3	(11),	and	BATF	(18),	whereas	Id3	inhibits	transcription	(19).	Outside	of	transcriptional	regulation,	it	is	not	known	if	other	mechanisms	are	important	for	IL-9	expression.	MicroRNAs	(miRNAs)	are	one	such	mechanism.	These	are	double-stranded	RNAs	of	approximately	23bp	that	post-transcriptionally	regulate	gene	expression	by	inhibiting	translation	and	inducing	message	instability	(20,21).	Several	studies	have	identified	their	roles	in	Th	development.	First	of	all,	the	T	cell	specific	deletion	of	Drosha	or	Dicer	(RNases	required	for	miRNA	synthesis)	results	in	a	propensity	towards	Th1	development	and	a	significant	decrease	in	the	number	of	Tregs	(22-24).	In	addition,	multiple	individual	miRNAs	regulate	various	activities	in	Th	development	and	function.	They	are	thought	to	fine-tune	the	expression	of	genes	important	for	development	and	maintenance	of	the	stability	of	Th	cells	
	 4	
(25).	In	this	study	we	found	that	miRNAs	play	an	important	role	in	IL-9	expression	and	Th9	development	and	function,	and	we	used	them	as	a	tool	to	discover	the	significance	of	HIF-2α.			
MATERIALS	AND	METHODS		
Mouse	strains	and	isolation	of	naïve	T	cells	C57BL/6	(Charles	River,	Kent,	UK),	Rag2-/-,	and	CD4Cre	Dicerlox/lox	mice	were	kept	in	a	conventional	specific	pathogen-free	facility.	All	the	animal	work	was	performed	according	to	the	Animals	Scientific	Procedures	Act,	UK	under	the	animal	Project	Licence	70/6965.	Naïve	T	cells	(CD4+	CD62Lhigh	CD25-)	were	isolated	from	pooled	spleen	and	lymph	node	cells	of	8-16	week	old	mice,	first	using	the	Dynabeads®	Untouched™	Mouse	CD4	cells	kit	(Invitrogen,),	followed	by	biotinylated-anti-CD25	(7D4,	BD	Biosciences),	and	finally	biotinylated-anti-CD62L	(MEL-14,	BD	Biosciences),	with	the	last	two	steps	using	streptavidin-MicroBeads	(Miltenyi	Biotech).	Purity	of	cells	was	greater	than	90%	as	determined	by	flow	cytometry.			
Th	cell	development	and	analysis	Naïve	T	cells	were	activated	in	the	presence	of	plate-bound	anti-CD3/anti-CD28	antibodies	(eBioscience)	with	1µg/ml	anti-CD3	and	2µg/ml	anti-CD28	for	Th0,	Th1,	Th2	and	induced	Treg	(iTreg)	differentiation,	or	10µg/ml	anti-CD28	for	Th17	and	Th9	differentiation.	T	cells	were	differentiated	into	Th0	using	5µg/ml	anti-IFN-γ	(BD	Bioscience)	and	5µg/ml	anti-IL-4	(BD	Bioscience);	Th1	using	20ng/ml	recombinant-IL-12	(eBioscience)	and	5µg/ml	anti-IL-4;	Th2	using	20ng/ml	recombinant	IL-4	(BD	Bioscience)	and	5µg/ml	anti-IFN-γ;	Th17	using	2.5ng/ml	recombinant	TGF-β,	50ng/ml	recombinant	IL-6	(eBioscience),	5µg/ml	anti-IFN-γ,	5µg/ml	anti-IL-4,	and	5µg/ml	anti-IL-2	(BD	Bioscience);	Th9	using	2.5ng/ml	recombinant	TGF-β	(eBioscience),	40ng/ml	recombinant	IL-4,	and	10µg/ml	anti-IFN-γ;	and	iTregs	using	2.5ng/ml	recombinant	TGF-β	and	5ng/ml	recombinant-IL-2	(eBioscience).	Cells	
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were	cultured	for	3-4	days	prior	to	analysis.	For	intracellular	staining	of	cytokines,	cells	were	treated	with	1µg/ml	each	of	PMA	and	ionomycin	(Sigma)	for	four	hours	and	1µg/ml	of	brefeldin	A	(eBioscience)	for	two	hours	prior	to	staining.	For	Foxp3	staining,	cells	were	fixed	with	Foxp3	fixation/permeabilization	buffer	(eBioscience)	for	30	minutes	prior	to	staining,	and	if	GFP	was	also	detected,	cells	were	fixed	with	2%	paraformaldehyde	for	five	minutes	prior	to	fixation/permeabilization.	Antibodies	for	flow	cytometry	experiments	were:		CD4-FITC/PE/PerCP/allophycocyanin	(GK1.5),	CD8α-PerCP	(53-6.7),	CD25-PE	(PC61.5),	Foxp3-	allophycocyanin	(FJK-16s),	IFN-γ-FITC	(XMG1.2),	IL-17-PE	and	IL-9-eFlour®	660	(RM9A4)	(all	from	eBioscience),	and	IL-17a-PE	(TC11-18H10)	and	IL-4-PE	(11B11)	(BD	Biosciences).	Data	were	acquired	using	a	FACS	Canto	II	or	FACS	Calibur	(BD	Bioscience)	and	analysed	using	FlowJo	software	(Tree	Star).	Compensation	and	gate	lines	for	cytokine	and	Foxp3	staining	were	set	in	each	experiment	using	wild-type	cells	activated	under	Th0	polarizing	conditions	or	as	stated	for	the	individual	experiment.		
Retroviral	and	Lentiviral	production	The	miR-15b/16	expression	and	decoy	vectors	were	described	previously	(26).	The	expression	vector	was	derived	by	cloning	the	genomic	region	encoding	the	miRNAs	into	the	retroviral	pMIG	vector.	The	decoy	vector	was	designed	as	described	(27)	to	express	a	short	RNA	containing	miR-15b/16	target	sites.	The	decoy	sequence	was	cloned	into	the	pSIF	lentiviral	vector	for	Pol	III	expression.		Retrovirus	and	lentiviruses	were	produced	by	calcium	phosphate	transfection	of	human	embryonic	kidney	(HEK)	293T	cells	with	helper	virus	vectors.	Culture	supernatants	were	harvested	and	used	to	spin-infect	naïve	CD4+	T	cells	that	were	activated	overnight	by	plate	bound	anti-CD3/anti-CD28	antibodies.	Cells	were	then	differentiated	into	the	different	Th	subsets	as	described	above.		
Adoptive	T	cell-transfer	colitis	model	
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Naïve	T	cells	were	activated	and	retrovirally	transduced	then	FACS-sorted	for	GFP+	cells.	These	were	differentiated	under	Th9	polarizing	conditions,	and	106	cells	were	then	injected	into	the	peritoneal	cavity	of	C57BL/6	Rag2-/-	mice.	Weight	was	monitored	every	week,	and	mice	were	sacrificed	after	eight	weeks	(or	when	weight	decreased	by	20%)	for	analysis.		Histopathological	review	was	performed	blindly	as	previously	described	(28).			
Other	protocols	IL-9	was	measured	in	culture	supernatants	of	Th	differentiated	cells	after	48	hours	of	culture	using	murine	IL-9	ELISA	ready-SET-Go!	second-generation	kit	(eBioscience).	For	quantitative	RT-PCR	(qRT-PCR),	RNA	was	isolated	from	CD4+	T	cells	using	miRNAeasy	(for	miRNAs)	or	mRNAeasy	(for	mRNAs)	isolation	kits	(QIAGEN,	Manchester,	UK).	For	miRNA	detection,	cDNA	synthesis	and	subsequent	qRT-PCR	with	locked	nucleic	acid	primers	for	specific	miRNAs	was	performed	using	miRCURY	LNA™	universal	reverse	transcriptase	microRNA	cDNA	synthesis	and	qRT-PCR	kit	(EXIQON).		For	mRNA	detection,	cDNA	was	prepared	using	the	miRscript	cDNA	synthesis	kit	(QIAGEN).	qPCR	was	performed	using	IQ™	BioRad	SYBR	green	master	mix	(BioRad,	Hertfordshire,	UK).		Primer	sequences	are	available	upon	request.		For	Western	blotting,	rabbit	anti-HIF-2α	(ab179825)	(Abcam)	was	used.	For	siRNA	knockdown	of	Epas1	expression,	naïve	T	cells	were	transfected	with	siRNAs	using	Accell	deliver	medium	(all	from	Dharmacon)	following	manufacturer’s	protocols.	Luciferase	assays	were	performed	using	the	Dual-Luciferase	reporter	assay	system	(Promega)	from	extracts	prepared	from	HEK293T	cells	transfected	with	a	control	renilla	vector	and	the	firefly	reporter	containing	the	3’	untranslated	region	(UTR)	of	Epas1	downstream	of	the	luciferase	gene.				
Statistical	analysis:	
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Prism	software	(GraphPad)	or	Excel	was	used	for	statistical	analyses	to	calculate	mean	and	standard	deviation	values	from	independent	experiments	utilizing	different	pools	of	isolated	T	cells	or	in	the	case	of	the	adoptive	transfer	experiments,	individual	mice.	The	student’s	t-test	was	used	to	calculate	significance.	P	values	equal	to	or	less	than	0.05	were	considered	significant.		
	
RESULTS		
	
IL-9	expression	is	enhanced	in	Dicer-/-	T	cells	To	analyse	miRNA	control	of	IL-9	expression,	we	utilized	mice	with	a	T-cell	specific	deletion	of	Dicer	containing	a	floxed	allele	of	Dicer	and	a	CD4-Cre	transgene	(23).	As	a	starting	point,	IL-9	FACS	staining	was	optimized	utilizing	naïve	Th	cells	(CD4+	CD62Lhigh	CD25-)	activated	under	different	polarization	conditions.	Only	under	Th9	polarizing	conditions	were	substantial	numbers	of	IL-9-expressing	cells	observed	(Sup.	Fig.	1).	Therefore,	we	used	these	staining	conditions	in	subsequent	experiments.	Next,	IL-9	expression	was	examined	in	the	CD4+	population	of	spleen	and	lymph	node	cells	(or	isolated	CD4+	cells)	that	were	activated	by	PMA	and	ionomycin	and	that	were	from	either	CD4-Cre	Dicer+/lox	or	CD4-Cre	Dicerlox/lox	mice.	In	the	absence	of	miRNAs,	there	was	approximately	a	five-fold	increase	in	the	percentage	of	IL-9-producing	cells	on	average,	whereas	consistent	with	our	previous	results	(23),	there	was	a	decrease	in	the	numbers	of	Foxp3+	cells	(Fig.	1A).	Substantiating	this	increase	in	IL-9	expressing	cells	was	a	twelve-fold	increase	in	Il9	mRNA	in	Dicer-/-	ex	vivo	isolated	and		unstimulated	CD4+	CD25-	cells	(Fig	1A,	far	right).	Since	Th9	cells	are	the	main	producers	of	IL-9	(11,12),	we	examined	the	importance	of	miRNAs	on	Th9	differentiation	in	vitro	by	activating	naïve	Th	cells	under	Th9	polarizing	conditions	using	TGF-β	and	IL-4.	This	results	in	reduction	in	the	number	of	Foxp3+	cells	that	would	be	induced	by	TGF-β	alone,	and	it	produces	a	population	of	IL-9+	Foxp3-	cells	classically	defined	as	Th9	(12).	Dicer-/-	Th	cells	had	
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a	significant	decrease	in	the	percentage	of	Foxp3+	cells	and	a	significant	increase	in	the	percentage	of	IL-9+	Foxp3-	cells,	(Fig.	1B	and	Sup.	Fig.	2).	This	increase	in	IL-9	expressing	cells	was	also	substantiated	by	an	approximately	two-fold	increase	in	Il9	mRNA	in	Dicer-/-	cells	(Fig.	1B	far	right).	Therefore,	miRNAs	appear	to	suppress	Th9	differentiation.	Interestingly,	
Dicer-/-,	ex	vivo	isolated	Tregs	(CD4+	CD25+),	which	are	primarily	thymus-derived	Tregs,	also	had	approximately	a	two-fold	increase	in	the	percentage	of	IL-9-producing	cells	and	an	approximately	3.5-fold	increase	in	Il9	mRNA	(Fig.	1C).	Therefore,	miRNAs	also	appear	to	suppress	IL-9	expression	in	Tregs.		To	examine	if	miRNAs	suppress	IL-9	production	in	other	Th	subsets,	naïve	Th	cells	were	activated	under	different	polarization	conditions,	and	the	level	of	IL-9	production	was	measured	in	culture	supernatants	(Fig.	2A).	Dicer-/-	Th	cells	had	an	increase	in	IL-9	production	under	all	polarizing	conditions	tested,	particularly	in	Th2	and	iTreg	conditions	where	the	increase	was	to	the	same	level	found	in	Th9	cells.	Therefore,	miRNAs	play	a	general	role	in	suppressing	IL-9	expression	in	all	Th	polarization	conditions,	and	they	are	most	important	in	Th2	and	iTreg	conditions.	To	determine	if	miRNAs	supress	the	expression	of	IL-9	within	each	subset	or	alternatively	prevent	the	differentiation	towards	a	Th9	like	phenotype,	we	examined	IL-9	expression	in	combination	with	a	signature	marker	of	a	specific	Th	subset	(IFN-γ	for	Th1,	IL-4	for	Th2,	IL-17	for	Th17,	and	Foxp3	for	Tregs).	Consistent	with	previous	reports	(22,23,29),	loss	of	miRNAs	resulted	in	increased	production	of	IFN-γ	in	Th0	and	Th1	conditions	and	increased	IL-4	in	Th2	conditions,	whereas	there	was	a	slight	loss	of	IL-17	expression	under	Th17	conditions	and	a	significant	decrease	of	Foxp3	expression	in	induced	Tregs	(iTregs)	(Fig.	2B).	The	increase	in	IL-9	expression	in	all	subsets	but	iTregs	occurred	in	both	populations	of	cells	expressing	or	not	expressing	the	signature	cytokine.	Therefore,	miRNAs	appeared	to	be	important	regulators	of	IL-9	expression	within	these	subsets	but	also	important	for	inhibiting	differentiation	into	a	Th9-like	phenotype.	In	contrast,	the	increase	in	IL-9	expression	in	iTreg	induction	occurred	primarily	in	cells	not	expressing	Foxp3.	
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Therefore,	miRNAs	appeared	to	be	solely	important	for	the	lineage	choice	in	these	conditions	but	not	for	the	regulation	of	IL-9	expression	in	cells	with	an	iTreg	phenotype,	which	was	unlike	ex	vivo-isolated	Tregs	that	expressed	more	IL-9	in	the	absence	of	miRNAs.			
miR-15b/16	suppresses	IL-9	production	in	Th9	cells	To	begin	understanding	miRNA	regulation	of	IL-9	expression,	we	first	wanted	to	identify	individual	miRNAs	that	could	function	in	suppression.	Subsequently,	relevant	targets	could	be	determined	whose	regulation	impacted	IL-9	expression.	Because	loss	of	miRNAs	had	an	opposite	effect	on	the	differentiation	of	iTregs	and	Th9	cells,	we	decided	to	test	the	function	of	miRNAs	that	we	previously	found	to	be	important	for	iTreg	induction	(26)	and	determine	if	they	could	additionally	suppress	Th9	differentiation.	miR-15b	and	miR-16	were	two	of	these.	They	are	highly	related	miRNAs	encoded	on	the	same	primary	transcript	that	target	the	same	messages.	They	enhance	iTreg	induction	through	their	suppression	of	mTOR	and	Rictor,	which	inhibits	mTOR	signalling	and	directs	cells	into	a	Treg	differentiation	pathway.	We	previously	found	that	miR-15b	and	miR-16	were	more	abundantly	expressed	in	iTregs	than	in	naïve	T	cells	or	those	activated	under	Th0,	Th1,	Th2,	or	Th17	polarizing	conditions,	which	was	consistent	with	their	importance	in	iTreg	induction	(26).	Here	we	show	those	data	again	and	add	the	miR-15b	and	miR-16	expression	levels	in	Th9	cells,	which	were	also	much	lower	than	iTregs	(Fig.	3A).	Therefore,	miR15b/16	might	regulate	IL-9	expression	in	iTregs,	but	they	would	unlikely	be	important	in	other	subsets.	Nevertheless,	to	determine	if	miR-15b/16	were	capable	of	supressing	IL-9	expression,	we	examined	if	their	overexpression	could	inhibit	IL-9	expression	in	Th9	polarization	conditions.	Overexpression	was	achieved	utilizing	a	GFP-expressing	retrovirus	that	contained	the	genomic	sequence	encoding	both	miRNAs.	This	or	a	control,	empty	retrovirus	was	transduced	into	naïve	CD4+	T	cells	after	their	activation,	which	gave	on	average	twice	the	expression	level	of	these	miRNAs	in	iTregs	(Sup.	Fig.	3).	Cells	were	subsequently	activated	under	Th9	polarizing	conditions,	and	IL-9	expression	was	examined	in	
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transduced,	GFP+	cells.	miR15b/16	overexpression	resulted	in	a	significant	reduction	in	the	percentage	of	IL-9-producing	cells	and	the	level	of	IL-9	production	(Fig.	3B	and	C).	In	contrast,	miR-15b/16	overexpression	did	not	have	an	effect	on	the	low	numbers	of	cells	expressing	IL-9	in	Th1,	Th2,	Th17,	or	iTreg	polarizing	conditions	(Fig.	3D-G).	Likewise,	miR-15b/16	overexpression	did	not	affect	the	development	of	Th1,	Th2,	or	Th17	cells	as	measured	by	the	expression	of	signature	cytokines,	but	consistent	with	our	previous	findings,	it	did	enhance	iTreg	induction	(26).		Therefore,	miR15b/16	appear	to	be	capable	of	regulating	Th9	and	iTreg	differentiation	but	not	other	subsets.				miR-15b/16	inhibits	the	inflammatory	response	of	Th9	cells	in	vivo	Because	Th9	cells	are	important	in	autoimmunity,	we	examined	if	miR-15b/16	could	inhibit	their	inflammatory	response.	In	vitro-derived	Th9	cells	will	produce	an	autoimmune	response	in	the	colon	when	they	are	adoptively	transferred	into	Rag2-/-	mice	(11).	Therefore,	we	tested	if	miR-15b/16	overexpression	could	inhibit	this	activity.	Naïve	CD4+	CD25-	T	cells	were	activated	then	transduced	with	control	or	miR-15b/16	expressing	retroviruses.	GFP+	cells	were	sorted	then	further	activated	under	Th9	polarizing	conditions	before	their	adoptive	transfer	into	Rag2-/-	mice.	miR-15b/16	overexpression	significantly	inhibited	weight	loss	(Fig.	3A)	and	reduced	the	resultant	colitis	as	measured	by	colon	thickness	(Fig.	4B).	Analysis	of	GFP+	cells	recovered	from	the	spleen	revealed	that	miR-15b/16	overexpression	reduced	the	number	of	IL-9-producing	CD4+	cells	(Fig.	4C).	However,	miR-15b/16	overexpression	also	resulted	in	an	increase	in	the	number	of	Tregs	(Fig.	4D)	so	it	was	uncertain	if	the	reduced	inflammatory	response	was	due	to	the	reduction	in	Th9	cells	or	an	increase	in	Tregs.	Nevertheless,	the	effects	of	miR-15b/16	overexpression	on	IL-9	expression	in	Th9	polarization	observed	in	vitro	were	maintained	in	vivo	over	the	time	course	of	this	experiment.				
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Epas1,	encoding	the	hypoxia	transcription	factor	HIF-2α,	can	be	regulated	by	miR-15b/16	Because	miR-15b/16	could	regulate	the	expression	of	IL-9,	and	because	these	miRNAs	are	highly	expressed	only	in	Tregs,	we	hypothesized	that	miR-15b/16	might	be	important	for	regulating	IL-9	expression	in	Tregs.	Therefore,	we	searched	for	potential	target	genes	using	target	prediction	algorithms	(30).	Because	true	target	genes	would	most	likely	be	more	highly	expressed	in	Dicer-/-	Tregs,	potential	targets	of	miR-15b/16	were	manually	examined	for	those	that	were	more	highly	expressed	in	Dicer-/-	compared	to	Dicer+/+	Tregs	using	gene	expression	array	data	(31).	Epas1	was	one	gene	found	in	this	analysis,	which	encodes	the	hypoxia	inducible	factor	HIF-2α.	HIF-2α	or	its	related	gene	product,	HIF-1α,	associates	with	HIF-1β	(also	known	as	the	aryl	hydrocarbon	receptor	nuclear	translocator	ARNT).	These	heterodimers	act	as	transcription	factors	to	regulate	gene	expression	for	cell	survival	in	low	oxygen	environments	(32).	HIFs	play	important	roles	in	cancer	biology	due	to	the	hypoxic	conditions	that	develop	as	tumors	grow	(33).	Originally,	the	HIF-α	subunits	were	thought	to	be	interchangeable,	but	recent	evidence	has	found	differences	in	their	function	(33).	HIF-1α	plays	a	complicated	role	in	Th	development	in	that	it	has	been	found	to	be	important	for	the	development	of	Th17	cells	over	Tregs	(34,35),	but	it	is	also	important	for	Treg	function	(36).	In	contrast,	virtually	nothing	is	known	about	the	function	of	HIF-2α	in	Th	development.	Therefore,	its	regulation	by	miRNAs	was	examined.		
Epas1	RNA	was	abundantly	expressed	in	Th9-polarized	cells,	which	was	consistent	with	a	role	in	IL-9	expression.	However,	it	was	also	abundant	in	Th2-polarized	cells	(Fig.	5A),	but	whereas	the	highest	RNA	level	was	found	in	Th2-polarized	cells,	the	highest	protein	level	was	found	in	Th9-polarized	cells	(Fig.	5C).	In	either	case,	it	was	less	expressed	in	Tregs	and	other	Th	subsets.	Therefore,	its	abundant	expression	in	Th9	cells	was	consistent	with	a	role	in	IL-9	expression.	However,	its	expression	in	Th2	cells	indicated	that	it	most	likely	would	not	be	sufficient.	
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The	expression	of	Epas1	was	regulated	by	miRNAs,	as	there	was	a	significant	increase	in	mRNA	levels	in	ex	vivo-isolated	CD4+	conventional	T	cells	(Tcon)	(CD25-)	and	Tregs	(CD25+)	that	lacked	miRNAs	(Fig.	5B).	Likewise,	HIF-2α	protein	levels	were	increased	in	Dicer-/-	T	cells	that	were	activated	under	all	polarization	conditions	tested	(Fig.	5C).	Therefore,	expression	of	HIF-2α	could	be	regulated	by	miR-15b/16	in	Tregs,	but	other	miRNAs	would	most	likely	be	important	in	other	subsets	because	as	stated	above,	miR-15b/16	are	only	abundantly	expressed	in	Tregs.		Nevertheless,	we	examined	regulation	of	HIF-2α	expression	by	miR-15b/16.	The	activity	of	a	luciferase	reporter	gene	containing	the	Epas1	3’UTR	was	suppressed	by	the	co-expression	of	miR-15b/16,	and	this	suppression	was	significantly	reduced	if	the	predicted	miR-15b/16	target	site	was	mutated	(Fig.	5D).	In	addition,	expression	of	Epas1	RNA	and	HIF-2α	protein	was	suppressed	in	Th9-polarized	cells	by	the	overexpression	of	miR-15b/16	(Fig.	5E).	Therefore,	miR15b/16	can	regulate	the	expression	of	Epas1.	
HIF-2a	regulates	the	development	of	Th9	cells	and	iTregs	To	test	the	importance	of	HIF-2α	in	the	development	of	Th9	cells,	the	effect	of	altering	its	expression	was	analysed.	Transfection	of	an	siRNA	against	Epas1	reduced	the	percentage	of	IL-9-producing	cells	when	activated	under	Th9	polarizing	conditions,	whereas	it	enhanced	the	production	of	Foxp3+	cells	(Fig.	6A).	The	observed	decrease	in	the	numbers	of	IL-9	expressing	cells	was	substantiated	by	the	reduced	production	of	IL-9	in	culture	supernatants	from	these	cultures	(Fig.	6A).		In	contrast	to	the	siRNA	knockdown,	overexpression	of	HIF-2α	using	a	retrovirus	containing	the	Epas1	cDNA,	enhanced	the	percentage	of	IL-9-producing	cells	and	decreased	the	production	of	Foxp3+	cells	(Fig.	6B).	Overexpression	of	Epas1	also	inhibited	the	induction	of	iTregs	in	iTreg	conditions,	but	as	in	the	Foxp3+	cells	in	Th9	polarization	conditions,	it	did	not	increase	IL-9	expression.	Therefore,	expression	of	HIF-2α	is	also	not	sufficient	for	IL-9	expression	in	iTregs.	Other	regulatory	factors	specific	to	Th9	cells	must	also	be	required.	To	test	the	importance	of	miR-15b/16	suppression	of	HIF-2α	expression	in	Tregs,	naïve	T	cells	were	activated	and	transduced	with	a	lentivirus	expressing	
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a	miR-16	decoy	that	acted	as	a	competitive	inhibitor	of	miR-15b/16.	These	cells	were	then	differentiated	under	iTreg	conditions.	Inhibiting	the	high	levels	of	miR-16	in	Tregs	increased	the	expression	of	Epas1	mRNA	and	HIF-2α protein	(Fig	6D),	and	consistent	with	our	previous	results	(26)	it	inhibited	iTreg	induction,	but	ironically	it	did	not	increase	IL-9	expression	(Fig.	6E).	Therefore,	the	loss	of	miR15b/16	expression	in	Dicer-/-	iTregs	is	not	sufficient	for	the	developmental	changes	that	lead	to	some	cells	with	a	Th9	like	phenotype.	Other	miRNAs	must	be	important	in	iTregs	and	also	for	regulation	of	IL-9	expression	in	other	subsets.	Nevertheless,	miR15b/16	appear	to	be	one	means	of	suppressing	the	expression	of	HIF-2α	in	iTregs	and	preventing	its	inhibitory	effects	on	iTreg	induction.			
DISCUSSION		In	this	report	we	have	demonstrated	that	miRNAs	regulate	the	expression	of	IL-9	in	Th	cells.	Two	highly	related	miRNAs,	miR-15b	and	miR-16,	were	found	capable	of	suppressing	IL-9	expression	when	overexpressed	in	Th9	cells.	These	miRNAs	were	able	to	regulate	the	hypoxia	transcription	factor	gene	Epas1	(encoding	HIF-2α),	which	was	found	to	be	important	for	IL-9	expression	in	Th9	cells.		This	study	demonstrated	the	utility	of	examining	miRNA	function	to	identify	new	regulatory	pathways	in	Th	development	and	function.	However,	the	irony	is	that	the	miRNAs	analysed	(miR-15b/16)	are	probably	not	directly	relevant	for	regulating	IL-9	expression	in	vivo	because	1)	they	could	only	supress	IL-9	expression	when	they	were	overexpressed	in	Th9	cells;	2)	they	are	not	abundantly	expressed	in	Th0,	Th1,	Th2,	and	Th17	cells,	in	which	IL-9	expression	is	low	so	they	are	unlikely	to	be	important	regulators	in	these	subsets;	and	3)	in	iTregs	where	miR-15b/16	are	abundantly	expressed,	blocking	their	function	did	not	induce	IL-9	expression.	Therefore,	other	miRNAs	must	be	responsible	for	the	increased	IL-9	expression	observed	in	Dicer-/-	T	cells.	Nevertheless,	miR-15b/16	regulation	of	HIF-2α	expression	in	iTregs	appears	to	be	one	mechanism	of	suppressing	the	expression	of	HIF-2α	
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and	preventing	its	inhibitory	function	on	iTreg	induction.	Therefore,	HIF-2α	appears	to	be	an	additional	target	of	miR-15b/16	in	iTregs	that	explains	the	importance	of	these	two	miRNAs	in	iTreg	induction.	All	these	findings	are	summarized	in	the	diagram	in	figure	7.	The	suppression	of	iTreg	induction	by	HIF-2α	and	its	importance	for	the	expression	of	IL-9	in	Th9	cells	adds	new	information	to	the	function	of	the	HIF	proteins	in	Th	development.	As	mentioned	above,	HIF-1α	plays	a	complicated	role	in	Th	development	with	many	questions	regarding	its	functions	(37).	HIF-1α	is	reported	to	enhance	Th17	over	Treg	development	(34,35),	but	it	is	also	required	for	Treg	function	(36).	In	Th17	cells,	HIF-1α	associates	with	the	transcription	factor	RORγt	to	regulate	transcription	of	genes	important	for	Th17	development.	It	also	inhibits	Treg	development	through	its	association	with	Foxp3,	which	targets	it	for	degradation	through	the	proteasome	(35).	However,	hypoxia	also	directly	activates	FoxP3	expression	and	the	induction	of	Tregs	(36).	Therefore,	the	details	of	HIF-1α	function	need	further	understanding.	HIF-2α	appears	to	regulate	the	differentiation	between	Th9	and	Tregs	analogous	to	HIF-1α	in	the	Th17/Treg	axis.	However,	the	mechanisms	of	HIF-2α	activating	IL-9	expression	and	suppressing	Treg	induction	will	need	to	be	explored.	With	IL-9	expression,	clearly	HIF-2α	is	not	sufficient	by	itself	because	its	relevantly	abundant	expression	in	Th2	cells	or	its	overexpression	in	iTregs	does	not	lead	to	high	expression	of	IL-9.	Other	factors	specific	to	Th9	cells	must	also	be	required.	Finally,	both	HIF-1α	and	HIF-2α	are	regulated	by	oxygen	levels	through	hydroxylation	of	key	proline	residues,	which	leads	to	their	degradation	by	the	proteasome.	In	T	cells	HIF-1α	is	also	stabilized	under	normal	oxygen	conditions	by	TCR	stimulation	or	IL-6	signalling	through	STAT3	(35,38).	Therefore,	regulation	of	HIF	protein	expression	plays	an	important	role	in	the	diverse	environments	encountered	by	T	cells	in	vivo.		
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Regulation	of	IL-9	expression	is	controlled	by	many	mechanisms,	and	this	work	has	illustrated	the	importance	of	miRNAs	and	HIF-2α.	Therefore,	it	will	be	important	to	understand	how	all	these	combine	to	regulate	IL-9	expression	in	an	immune	response.	
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Figure	1.	miRNAs	suppress	IL-9	expression	in	Th	cells.	A.	Spleen	and	lymph	node	cells	from	CD4	Cre	Dicer+/lox	or	CD4	Cre	Dicerlox/lox	mice	were	activated	by	PMA	and	ionomycin	for	four	hours	with	brefeldin	A.	The	analysis	of	Foxp3	APC	and	either	IL-9	PE	or	IL-9	FMO	control	is	shown	on	the	CD4+	population	of	activated	(as	determined	by	SSC	and	FSC)	cells.	To	the	right,	the	mean	and	standard	deviation	values	are	shown	from	seven	independent	experiments	(using	either	spleen	and	lymph	node	cells	or	isolated	CD4+	cells)	indicating	a	significant	increase	in	IL-9	expressing	cells	when	Dicer	is	absent	(**p=0.002).	Substantiating	this	and	shown	at	the	far	right	was	an	increase	in	the	relative	level	of	Il9	mRNA	in	ex	vivo-isolated	CD4+	CD25-	cells	(as	measured	by	qRT-PCR	and	normalized	to	GAPDH)	(*p=0.02	from	5	independent	experiments).	B.	Naïve	CD4+	T	cells	were	activated	under	Th9-polarization	conditions,	and	IL-9	and	Foxp3	expression	was	analysed	by	FACS	as	in	A.	There	was	a	significant	increase	in	IL-9	expressing	cells	when	miRNAs	were	absent	(*p=0.02	from	four	independent	experiments).	Likewise,	there	was	a	significant	increase	in	the	relative	level	of	
Il9	mRNA	(*p=0.02	from	five	independent	experiments).	C.	Isolated	Tregs	(CD4+	CD25+)	also	displayed	an	increase	in	IL-9	expression	in	Dicer-/-	cells	(*p=0.01	for	FACS	and	*p=0.04	for	Il9	mRNA	from	three	or	five	independent	experiments,	respectfully).		
Figure	2.	miRNAs	suppress	IL-9	expression	in	all	Th	subsets.	A.	Naïve	CD4+	cells	containing	(Dicer+/-)	or	lacking	(Dicer-/-)	miRNAs	were	activated	under	the	indicated	polarization	conditions	for	48	hours,	and	the	level	of	IL-9	was	determined	by	ELISA	from	culture	supernatants.	Values	are	from	three	independent	experiments.	Cells	lacking	miRNAs	expressed	significantly	more	IL-9:		Th0	(***p=0.0003),	Th1	(*p=0.03),	Th2	(******p=0.0000008),	Th9	(*p=0.05),	Th17	(**p=0.002)	and	iTregs	(***p=0.0003).	B.	Representative	profiles	from	3-4	independent	experiments	showing	expression	of	signature	cytokines	(or	Foxp3	for	iTregs)	and	IL-9	for	indicated	polarization	conditions.			
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Figure	3.	Overexpression	of	miR-15b/16	suppresses	the	expression	of	IL-9	during	Th9	
polarization	but	has	no	effect	on	Th1,	Th2,	or	Th17	polarization.	A.	Relative	miRNA	levels	of	miR15b	and	miR-16	normalized	to	5S	rRNA	(as	determined	by	qRT-PCR)	from	naïve	CD4+	T	cells	activated	under	the	indicated	polarization	conditions.	Th9	levels	are	added	for	comparison	to	data	from	our	previous	report	(26)	of	levels	in	other	subsets.	B-G.	T	cells	transduced	with	a	control	or	miR	15b/16	overexpressing	retrovirus	were	activated	under	the	indicated	polarization	conditions.	Th	differentiation	in	the	GFP+	cell	population	was	measured	by	the	percentage	of	cells	expressing	the	signature	cytokine	(B,	D-F)	or	Foxp3	for	iTregs	(G).	A	representative	experiment	is	on	the	left,	and	the	mean	and	standard	deviation	values	are	on	the	right	for	four	independent	experiments.	Only	in	Th9	polarized	cells	was	the	percentage	of	IL-9	expressing	cells	significantly	different	(*p=0.02).	C.	mR-15b/16	overexpressing	cells	produce	less	IL-9	during	Th9	polarization,	as	measured	by	ELISA	from	culture	supernatants.	Data	are	from	three	independent	experiments	(**p=0.001).		
Figure	4.	miR-15b/16	overexpression	suppress	the	inflammatory	response	of	Th9	cells.	
A.	&	B.	Naïve	CD4+	cells	were	activated	then	transduced	with	control	or	miR-15b/16	expressing	retroviruses.	GFP+	cells	were	sorted	then	differentiated	under	Th9	polarization	conditions	and	adoptively	transferred	into	Rag2-/-	mice	as	described	in	Materials	and	Methods.	Weight	loss	(A)	was	significantly	inhibited	when	Th9	differentiated	cells	overexpressed	miR-15b/16	(**p=0.002),	as	was	the	resultant	colitis	(B)	as	measured	by	colon	thickness	(*p=0.03).		C.	&	D.	Spleen	cells	were	isolated	from	the	above	mice	and	activated	by	anti-CD3	and	anti-CD28	then	GFP+	cells	(which	derived	from	the	original	adoptively	transferred	cells)	were	analysed	for	expression	of	IL-9	(C)	or	Foxp3	(D)	in	combination	with	CD4.	A	representative	experiment	is	shown	on	the	left	and	the	mean	and	standard	deviation	values	on	the	right,	which	show	a	significant	decrease	in	IL-9	expressing	cells	(**p=0.005)	and	
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a	significant	increase	in	Foxp3	expressing	cells	(**p=0.006).	Data	are	derived	from	four	mice	per	group.				
Figure	5.	HIF-2α	is	regulated	by	miR-15b/16	overexpression.	A.	Epas1	mRNA	levels	normalized	to	GAPDH	(as	measured	by	qRT-PCR)	and	relative	to	naïve	T	cells	are	highest	in	T	cells	differentiated	under	Th2	and	Th9	conditions.	Thymus-derived	Tregs	(tTregs)	are	ex	vivo	isolated	Tregs.	Data	are	from	4	independent	experiments.	B.	Dicer-/-	T	cells	have	significantly	increased	Epas1	mRNA	levels	in	both	Tcon	(CD25-)	(**p=0.002)	and	Tregs	(CD25+)	(**p=0.003).	Data	are	from	4	independent	experiments.	C.	HIF-2α	levels	are	highest	in	Th9	and	Th2	differentiated	cells,	and	levels	increase	in	all	helper	subsets	when	miRNAs	are	absent.	On	the	left	is	a	representative	Western	blot,	and	on	the	right	are	the	values	normalized	to	GADPDH	and	relative	to	Dicer+/-	Th0	cells	as	determined	by	densitometry	from	4	independent	experiments.	D.	Epas1	contains	a	miR15b/16	target	site	in	its	3’	UTR.	The	sequence	of	the	region	containing	the	miR-15b/16	target	site	in	a	luciferase	reporter	vector	with	the	Epas1	3’UTR	is	shown	as	well	as	the	sequence	of	a	mutated	reporter.	Below	is	the	sequence	of	miR-15b	showing	the	homology	through	the	seed	sequence.		When	the	wild	type	reporter	was	transfected	into	HEK	293T	cells,	it	was	significantly	repressed	by	the	co-expression	of	miR15b/16	(****p=0.00003),	and	suppression	was	significantly	reduced	with	the	reporter	containing	the	mutated	miR-15b/16	target	site	(**p=0.002).	E.	Overexpression	of	miR-15b/16	suppressed	Epas1	mRNA	and	HIF-2α	protein	expression	in	Th9	differentiated	cells.	mRNA	levels	are	derived	from	3	independent	experiments	(*p=0.04),	and	the	Western	blot	is	representative	of	two	independent	experiments	with	the	level	of	HIF-2α	relative	to	GAPDH	in	this	blot	(as	determined	by	densitometry)	shown	between.			
Figure	6.	HIF-2α	enhances	Th9	development	and	inhibits	iTreg	induction.	Naïve	CD4+	T	cells	were	activated	and	transfected	with	control	or	Epas1	siRNAs	(A)	or	transduced	with	
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control	or	Epas1	expressing	retroviruses	(B,	C)	or	with	a	control	or	a	miR-16	decoy	expressing	lentivirus	(D,	E).	Cells	were	then	activated	under	Th9	polarization	(A,	B)	or	iTreg	induction	(C,	D,	and	E)	conditions.	A.	An	Epas1	siRNA	inhibits	Th9	differentiation	(*p=0.02)	and	also	increases	the	number	of	Foxp3+	IL-9-	cells	in	these	conditions.	It	also	inhibits	the	production	of	IL-9	in	culture	supernatants	as	measured	by	ELISA	(*p=0.02).	The	levels	of	HIF-2α	as	measured	in	a	Western	blot	are	displayed	on	the	far	right.	B	&	C.	Overexpression	of	Epas1	enhances	Th9	differentiation	(*p=0.01)	and	inhibits	the	induction	of	iTregs	(**p=0.004).	D.	Expression	of	a	miR-16	decoy	during	the	induction	of	iTregs	enhances	the	expression	of	Epas1	(as	measured	by	qRT-PCR	and	normalized	to	GAPDH	*p=0.02)	and	also	HIF-2α	(as	measured	by	Western	blot	and	also	normalized	to	GAPDH).	E.	Despite	the	inhibition	of	iTreg	induction	by	the	miR-16	decoy	(*p=0.01),	it	does	not	increase	IL-9	expression	in	iTregs.	For	FACS	data,	a	representative	experiment	is	shown	with	the	mean	and	standard	deviation	values	from	four	to	six	experiments.	The	ELISA	and	Epas1	mRNA	data	are	derived	from	four	or	three	independent	experiments	respectfully,	and	the	HIF-2α	Western	blots	are	representative	of	two	independent	experiments	with	similar	results.	The	relative	levels	of	HIF-2α	normalized	to	GAPDH	for	these	blots	as	determined	by	densitometry	is	shown.				
Figure	7.	Summary	diagram	of	miRNA	and	HIF-2α	regulation	of	Th9	differentiation	and	
IL-9	expression.	miR-15b/16	play	important	regulatory	roles	in	iTregs.	Our	previous	work	demonstrated	that	these	miRNAs	enhance	iTreg	induction	through	supressing	mTOR	signalling.	In	this	work	we	have	found	that	they	also	enhance	iTreg	induction	through	supressing	HIF-2α	expression,	which	like	HIF-1α,	inhibits	iTreg	induction.	In	contrast,	HIF-2α	is	important	for	Th9	differentiation	but	not	sufficient	for	IL-9	expression	in	other	subsets.	Finally,	miR-15b/16	do	not	appear	to	be	the	important	miRNAs	for	regulating	IL-9	expression	in	all	Th	subsets.	Therefore,	as	yet	undefined	miRNAs	must	be	involved	in	supressing	Th9	differentiation	and	IL-9	expression	in	all	Th	subsets.			
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Supplemental Figure 1. Verification of IL-9 detection in FACS staining. Naïve CD4+ T cells were activated
under the indicated polarization conditions then cells were fixed and stained for IL-9 expression. A
representativeexperiment is shown demonstrating thegreatest expression in Th9 cells.
Supplemental Figure 2. Live/dead and unstimulated cell controls for IL-9 detection in Th9-differentiated T
cells. A. Naïve Dicer+/- and Dicer -/ - Th cells were activated under Th9 polarization conditions, and cells were
stained with IL-9 PE and the Fixable Viability Dye eFlour660 (FVD-660) (eBioscience), which can be
visualized in the APC channel. The IL-9 analysis is shown against the open FITC channel from both the live
and dead populations. B. Staining of Foxp3 APC and IL-9 PE from un-activated cells of the same preparation
used for A.
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Supplemental Figure 3. Expression levels of miR-15b and miR-16 in retrovirally transduced T cells relative
to iTregs. The relative expression of miR-15b and miR-16 was determined by qRT-PCR from T cells
transduced by a miR-15b/16 retrovirus or from those induced to become iTregs. Because of the difficulty of
measuring overexpression in the mixed population of transduced and untransduced cells, the comparison
with iTregs was made between cells with a similar transduction efficiency (~30%) and iTreg conversion
frequency (~40%). The mean values fromtwo independentexperimentswith similar results are shown.
